Transposon-mediated gene transfer into adult and induced pluripotent stem cells

Current Gene Therapy

Volumn 11, Issue 5, 2011, Pages 406-413

  Belay, Eyayu ^b   Dastidar, Sumitava ^a   van den Driessche, Thierry ^a,b   Chuah, Marinee K L ^a,b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Gene therapy; Gene transfer; Piggybac; Regenerative medicine; Sleeping beauty; Stem cells; Tol2; Transposon

Indexed keywords

LENTIVIRUS VECTOR; PIGGYBAC TRANSPOSASE; RETROVIRUS VECTOR; SLEEPING BEAUTY TRANSPOSASE; TRANSPOSASE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CD34 SELECTION; CELL DIFFERENTIATION; CELL LINEAGE; COMPARATIVE GENOMIC HYBRIDIZATION; DUCHENNE MUSCULAR DYSTROPHY; ELECTROPORATION; GENE CASSETTE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TRANSFER; GENETIC CODE; HEMATOPOIETIC STEM CELL; HUMAN; LONG TERMINAL REPEAT; MESENCHYMAL STEM CELL; MYOBLAST; NONHUMAN; NUCLEAR REPROGRAMMING; OSTEOGENESIS IMPERFECTA; PLASMID; PLURIPOTENT STEM CELL; STEM CELL GENE THERAPY; TRANSPOSON;

IPS; MAMMALIA;

EID: 80053478642     PISSN: 15665232     EISSN: 18755631     Source Type: Journal    
DOI: 10.2174/156652311797415836     Document Type: Article

References (59)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
2. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448: 318-24.
3. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007; 1: 55-70.
4. Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009; 136: 509-23.
5. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-20.
6. Okita K, Ichisaka T, Yamanaka S. Generation of germlinecompetent induced pluripotent stem cells. Nature 2007; 448: 313-7.
7. Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011; 474: 212-5.
8. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007; 318: 1920-3.
9. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008; 105: 5856-61.
10. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5: 111-123.
11. Pera MF. Stem cells: The dark side of induced pluripotency. Nature 2011; 471: 46-7.
12. Chun YS, Chaudhari P, Jang YY. Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease. Int J Biol Sci 2010; 6: 796-805.
13. Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Eng J Med 2010; 363: 355-64.
14. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669-672.
15. Aiuti A, Roncarolo MG. Ten years of gene therapy for primary immune deficiencies. Hematology/the Education Program of the American Society of Hematology 2009: 682-9.
16. VandenDriessche T. Gene therapy delivers. Hum Gene Ther 2009; 20: 1222-1223.
17. VandenDriessche T, Ivics Z, Izsvak Z, Chuah MK. Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. Blood 2009; 114: 1461-8.
18. Ivics Z, Izsvak Z. Transposons for gene therapy! Curr Gene Ther 2006; 6: 593-607.
19. Feschotte C, Pritham EJ. DNA transposons and the evolution of eukaryotic genomes. Ann Rev Genet 2007; 41: 331-68.
20. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
21. Mikkelsen JG, Yant SR, Meuse L, Huang Z, Xu H, Kay MA. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Mol Ther 2003; 8: 654-65.
22. Mates L, Izsvak Z, Ivics Z. Technology transfer from worms and flies to vertebrates: transposition-based genome manipulations and their future perspectives. Genome Biol 2007; 8 Suppl 1:S1.
23. Ivics Z, Kaufman CD, Zayed H, Miskey C, Walisko O, Izsvak Z. The Sleeping Beauty transposable element: evolution, regulation and genetic applications. Curr Iss Mol Biol 2004; 6: 43-55.
24. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997; 91: 501-10.
25. Ivics Z, Katzer A, Stuwe EE, Fiedler D, Knespel S, Izsvak Z. Targeted Sleeping Beauty transposition in human cells. Mol Ther 2007; 15: 1137-44.
26. Geurts AM, Yang Y, Clark KJ, Liu G, Cui Z, Dupuy AJ, et al. Gene transfer into genomes of human cells by the sleeping beauty transposon system. Mol Ther 2003; 8: 108-17.
27. Mates L, Chuah MK, Belay E, Jerchow B, Manoj N, Acosta-Sanchez A, et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 2009; 41: 753-61.
28. Cary LC, Goebel M, Corsaro BG, Wang HG, Rosen E, Fraser MJ. Transposon mutagenesis of baculoviruses: analysis of Trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses. Virology 1989; 172: 156-69.
29. Wu SC, Meir YJ, Coates CJ, Handler AM, Pelczar P, Moisyadi S, et al. piggy Bac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc Natl Acad Sci USA 2006; 103: 15008-13.
30. Lacoste A, Berenshteyn F, Brivanlou AH. An efficient and reversible transposable system for gene delivery and lineagespecific differentiation in human embryonic stem cells. Cell Stem Cell 2009; 5: 332-42.
31. Yusa K, Zhou L, Li MA, Bradley A, Craig NL. A hyperactive piggyBac transposase for mammalian applications. Proc Natl Acad Sci USA 2011; 108: 1531-6.
32. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, et al. piggy Bac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458: 766-70.
33. Yusa K, Rad R, Takeda J, Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 2009; 6: 363-9.
34. Hollis RP, Nightingale SJ, Wang X, Pepper KA, Yu XJ, Barsky L, et al. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon. Exp Hematol 2006; 34: 1333-1343.
35. Xue X, Huang X, Nodland SE, Mates L, Ma L, Izsvak Z, et al. Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 2009; 114: 1319-30.
36. Sumiyoshi T, Holt NG, Hollis RP, Ge S, Cannon PM, Crooks GM, et al. Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system. Hum Gene Ther 2009; 20: 1607-26.
37. Baus J, Liu L, Heggestad AD, Sanz S, Fletcher BS. Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol Ther 2005; 12: 1148-56.
38. Walisko O, Schorn A, Rolfs F, Devaraj A, Miskey C, Izsvak Z, et al. Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol Ther 2008; 16: 359-369.
39. Modlich U, Baum C. Preventing and exploiting the oncogenic potential of integrating gene vectors. J Clin Invest 2009; 119: 755-758.
40. Gabriel R, Eckenberg R, Paruzynski A, Bartholomae CC, Nowrouzi A, Arens A, et al. Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med 2009; 15: 1431-1436.
41. Van Damme A, Vanden Driessche T, Collen D, Chuah MK. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2002; 2: 195-209.
42. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
43. Belay E, Matrai J, Acosta-Sanchez A, Ma L, Quattrocelli M, Mates L, et al. Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: a nonviral paradigm for coaxed differentiation. Stem Cells 2010; 28: 1760-71.
44. Okita K, Hong H, Takahashi K, Yamanaka S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 2010; 5: 418-28.
45. Cadinanos J, Bradley A. Generation of an inducible and optimized piggyBac transposon system. Nucl Acids Res 2007; 35: e87.
46. Narsinh KH, Jia F, Robbins RC, Kay MA, Longaker MT, Wu JC. Generation of induced pluripotent stem cells using non viral minicircles DNA vectors. Nat Protoc 2011; 6: 78-88.
47. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7: 618-20.
48. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4: 472-6.
49. Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, et al. Efficient generation of trangene free human induced pluripotent stem cells (iPSCs) by temperature-sensative Sendai virus vectors. Proc Natl Acad Sci USA 2011.
50. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011; 8: 409-12.
51. Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, Lindgren A, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009; 27: 806-11.
52. Huang X, Guo H, Tammana S, Jung YC, Mellgren E, Bassi P, et al. Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells. Mol Ther 2010; 18: 1803-13.
53. Wang W, Lin C, Lu D, Ning Z, Cox T, Melvin D, et al. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci USA 2008; 105: 9290-5.
54. Montini E, Cesana D, Schmidt M, Sanvito F, Bartholomae CC, Ranzani M, et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 2009; 119: 964-975.
55. Dalsgaard T, Moldt B, Sharma N, Wolf G, Schmitz A, Pedersen FS, et al. Shielding of sleeping beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells. Mol Ther 2009; 17: 121-30.
56. Wilson MH, George AL, Jr. Designing and testing chimeric zinc finger transposases. Methods Mol Biol 2010; 649: 353-63.
57. Garrison BS, Yant SR, Mikkelsen JG, Kay MA. Postintegrative gene silencing within the Sleeping Beauty transposition system. Mol Cell Biol 2007; 27: 8824-33.
58. Albieri I, Onorati M, Calabrese G, Moiana A, Biasci D, Badaloni A, et al. A DNA transposon-based approach to functional screening in neural stem cells. J Biotech 2010; 150: 11-21.
59. Hackett PB, Largaespada DA, Cooper LJ. A transposon and transposase system for human application. Mol Ther 2010; 18: 674-83.